Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lujun Shen

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Annals of Translational Medicine|March 12, 2021
Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective studyZhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Nature Communications|June 10, 2018
Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series dataLujun Shen, Qi Zeng, Pi Guo, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 8, 2024
Cryoablation-induced neutrophil Ca<sup>2+</sup> elevation and NET formation exacerbate immune escape in colorectal cancer liver metastasisHongtong Tan, Yiquan Jiang, Lujun Shen, et al.
Frontiers in Pharmacology|January 1, 2021
Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer AnalysisLujun Shen, Qifeng Chen, Changsheng Yang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term resultsLuwen Mu, Lin Sun, Tao Pan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2025
The Value of no Evidence of Disease (NED) in Intermediate-Stage Hepatocellular Carcinoma After TACE: A Real-World StudyLujun Shen, Yiquan Jiang, Yueqian Wu, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2022
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractorinessTao Huang, Han Qi, Lujun Shen, et al.
Journal of Cancer Research and Therapeutics|July 16, 2021
Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolizationYing Liu, Menting Shi, Shuanggang Chen, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2020
Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort studyLujun Shen, Han Qi, Shuanggang Chen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 24, 2020
Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysisShuanggang Chen, Mengting Shi, Lujun Shen, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Annals of Translational Medicine|March 12, 2021
Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective studyZhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Nature Communications|June 10, 2018
Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series dataLujun Shen, Qi Zeng, Pi Guo, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 8, 2024
Cryoablation-induced neutrophil Ca<sup>2+</sup> elevation and NET formation exacerbate immune escape in colorectal cancer liver metastasisHongtong Tan, Yiquan Jiang, Lujun Shen, et al.
Frontiers in Pharmacology|January 1, 2021
Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer AnalysisLujun Shen, Qifeng Chen, Changsheng Yang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term resultsLuwen Mu, Lin Sun, Tao Pan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2025
The Value of no Evidence of Disease (NED) in Intermediate-Stage Hepatocellular Carcinoma After TACE: A Real-World StudyLujun Shen, Yiquan Jiang, Yueqian Wu, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2022
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractorinessTao Huang, Han Qi, Lujun Shen, et al.
Journal of Cancer Research and Therapeutics|July 16, 2021
Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolizationYing Liu, Menting Shi, Shuanggang Chen, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2020
Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort studyLujun Shen, Han Qi, Shuanggang Chen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 24, 2020
Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysisShuanggang Chen, Mengting Shi, Lujun Shen, et al.
Pageof 10